IBS

Crohns disease stock photo

J&J's Stelara fails to top Humira in head-to-head Crohn's study

Stelara didn't prove superior to Humira in a Crohn's head-to-head—at least not efficacy-wise—but J&J figures the safety stats offer an edge.

Fraiser Kansteiner May 23, 2021 4:14pm

Bausch Health headquarters formerly Valeant

Salix shines a light on IBS patients' pandemic suffering

Apr 28, 2021 10:10am

AstraZeneca

AZ takes full China rights to Ironwood's IBS-C star Linzess

Sep 18, 2019 10:40am

hope for the best

Can Zelnorm compete in IBS-C a decade after recall?

Sep 17, 2019 6:50pm

Profit per room in the US reached the highest levels recorded for the year this past October a report from data analyst Ho

Sandoz SXSW hackathon names 3 winners

Mar 13, 2019 9:33am

Bausch Health headquarters formerly Valeant

Cosmo wins FDA green light to challenge Bausch's Xifaxan

Nov 20, 2018 11:43am